High expression of CAI2, a9p21-embedded long noncoding RNA, contributes to advanced-stage neuroblastoma

Cancer Research

Volumn 74, Issue 14, 2014, Pages 3753-3763

  Barnhill, Lisa M ^a   Williams, Richard T ^a   Cohen, Olga ^a   Kim, Youngjin ^a   Batova, Ayse ^a   Mielke, Jenna A ^a   Messer, Karen ^b   Pu, Minya ^b   Bao, Lei ^b   Yu, Alice L ^a,c,d   Diccianni, Mitchell B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c ACADEMIA SINICA   (Taiwan)

^d CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ARF PROTEIN; LONG UNTRANSLATED RNA; MESSENGER RNA; PROTEIN P16;

ADVANCED CANCER; ARTICLE; CAI2 GENE; CANCER CELL CULTURE; CANCER STAGING; CELL PROLIFERATION; CELL TRANSFORMATION; CHILD; CONTROLLED STUDY; EXON; GENE LOCATION; GENE LOCUS; GENE OVEREXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRON; MAJOR CLINICAL STUDY; MARKER GENE; NEUROBLASTOMA; NEWBORN; NUCLEOTIDE SEQUENCE; PRIMARY TUMOR; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ADP-RIBOSYLATION FACTORS; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; CHILD; CHILD, PRESCHOOL; CHROMOSOMES, HUMAN, PAIR 9; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FOLLOW-UP STUDIES; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE ORDER; HUMANS; INFANT; INFANT, NEWBORN; NEOPLASM STAGING; NEUROBLASTOMA; PROGNOSIS; RNA, LONG NONCODING; RNA, MESSENGER;

EID: 84904253761     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-13-3447     Document Type: Article

References (43)

1. Malecova B, Morris KV. Transcriptional gene silencing through epigenetic changes mediated by non-coding RNAs. Curr Opin Mol Ther 2010;12:214-22.
2. Ponting CP, Oliver PL, Reik W. Evolution and functions of long noncoding RNAs. Cell 2009;136:629-41.
3. Mattick JS, Taft RJ, Faulkner GJ. A global view of genomic information-moving beyond the gene and the master regulator. Trends Genet 2010;26:21-8.
4. Szell M, Bata-Csorgo Z, Kemeny L. The enigmatic world of mRNA-like ncRNAs: their role in human evolution and in human diseases. Semin Cancer Biol 2008;18:141-8.
5. Ellis BC, Molloy PL, Graham LD. CRNDE: A long non-coding RNA involved in cancer, neurobiology, and development. Front Genet 2012;3:270.
6. Gupta RA, Shah N,Wang KC, Kim J, Horlings HM, Wong DJ, et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 2010;464:1071-6.
7. Chisholm KM, Wan Y, Li R, Montgomery KD, Chang HY, West RB. Detection of long non-coding RNA in archival tissue: correlation with polycomb protein expression in primary and metastatic breast carcinoma. PloS ONE 2012;7:e47998.
8. Lv XB, Lian GY, Wang HR, Song E, Yao H, Wang MH. Long noncoding RNA HOTAIR is a prognostic marker for esophageal squamous cell carcinoma progression and survival. PloS ONE 2013;8:e63516.
9. Kim K, Jutooru I, Chadalapaka G, Johnson G, Frank J, Burghardt R, et al. HOTAIR is a negative prognostic factor and exhibits prooncogenic activity in pancreatic cancer. Oncogene 2013;32:1616-25.
10. Diccianni MB, Chilcote RR, Yu A. The genes of chromosomes 9p21 (p16, p15, ARF, MTAP) in pediatric acute leukemia: inactivation and exploitation for tumor-targeted therapeutics. Trends Cancer Res 2007;2:135-49.
11. Gil J, Peters G. Regulation of the INK4b-ARF-INK4a tumour suppressor locus: all for one or one for all. Nat Rev Mol Cell Biol 2006;7:667-77. (Pubitemid 44268212)
12. Pasmant E, Sabbagh A, Vidaud M, Bieche I. ANRIL, a long, noncoding RNA, is an unexpected major hotspot in GWAS. FASEB J 2011;25:444-8.
13. Pasmant E, Laurendeau I, Heron D, Vidaud M, Vidaud D, Bieche I. Characterization of a germ-line deletion, including the entire INK4/ARF locus, in a melanoma-neural system tumor family: identification of ANRIL, an antisense noncoding RNA whose expression coclusters with ARF. Cancer Res 2007;67:3963-9. (Pubitemid 46762186)
14. Yu W, Gius D, Onyango P, Muldoon-Jacobs K, Karp J, Feinberg AP, et al. Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA. Nature 2008;451:202-6.
15. Visel A, Zhu Y, May D, Afzal V, Gong E, Attanasio C, et al. Targeted deletion of the 9p21 non-coding coronary artery disease risk interval in mice. Nature 2010;464:409-12.
16. Wan G, Mathur R, Hu X, Liu Y, Zhang X, Peng G, et al. Long non-coding RNA ANRIL (CDKN2B-AS) is induced by the ATM-E2F1 signaling pathway. Cell Signal 2013;25:1086-95.
17. Bochenek G, Hasler R, El Mokhtari NE, Konig IR, Loos BG, Jepsen S, et al. The large non-coding RNA ANRIL, which is associated with atherosclerosis, periodontitis and several forms of cancer, regulates ADIPOR1, VAMP3 and C11ORF10. Hum Mol Genet 2013;22:4516-27.
18. Yu AL, Gilman AL, Ozkaynak MF, London WB, Kreissman SG, Chen HX, et al. Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma. N Engl J Med 2010;363:1324-34.
19. Diccianni MB,Omura-Minamisawa M, Batova A, Le T, Bridgeman L, Yu AL. Frequent deregulation of p16 and the p16/G1 cell cycle-regulatory pathway in neuroblastoma. Int J Cancer 1999;80:145-54. (Pubitemid 28559791)
20. Omura-Minamisawa M, Diccianni MB, Chang RC, Batova A, Bridgeman LJ, Schiff J, et al. p16/p14(ARF) cell cycle regulatory pathways in primary neuroblastoma: p16 expression is associated with advanced stage disease. Clin Cancer Res 2001;7:3481-90. (Pubitemid 33069984)
21. Lin YC, Diccianni MB, Kim Y, Lin HH, Lee CH, Lin RJ, et al. Human p16gamma, a novel transcriptional variant of p16(INK4A), coexpresses with p16(INK4A) in cancer cells and inhibits cell-cycle progression. Oncogene 2007;26:7017-27. (Pubitemid 350017588)
22. Diccianni MB, Chau LS, Batova A, Vu TQ, Yu AL. The p16 and p18 tumor suppressor genes in neuroblastoma: implications for drug resistance. Cancer Lett 1996;104:183-92. (Pubitemid 26181008)
23. Summerhill EM, Wood K, Fishman MC. Regulation of tyrosine hydroxylase gene expression during differentiation of neuroblastoma cells. Brain Res 1987;2:99-103. (Pubitemid 17100356)
24. Thiele CJ. Neuroblastoma. In:Masters J, editor. Human cell culture. UK: Kluwer Academic Publishers; 1998. p. 21-35.
25. Lin RJ, Lin YC, Chen J, Kuo HH, Chen YY, Diccianni MB, et al. microRNA signature and expression of Dicer and Drosha can predict prognosis and delineate risk groups in neuroblastoma. Cancer Res 2010;70:7841-50.
26. Chen Y, Stallings RL. Differential patterns of microRNA expression in neuroblastoma are correlated with prognosis, differentiation, and apoptosis. Cancer Res 2007;67:976-83.
27. Yu M, Ohira M, Li Y, Niizuma H, Oo ML, Zhu Y, et al. High expression of ncRAN, a novel non-coding RNA mapped to chromosome 17q25.1, is associated with poor prognosis in neuroblastoma. Int J Oncol 2009;34:931-8.
28. Zhu Y, Yu M, Li Z, Kong C, Bi J, Li J, et al. ncRAN, a newly identified long noncoding RNA, enhances human bladder tumor growth, invasion, and survival. Urology 2011;77:510.e1-5.
29. Castelnuovo M, Massone S, Tasso R, Fiorino G, Gatti M, Robello M, et al. An Alu-like RNA promotes cell differentiation and reduces malignancy of human neuroblastoma cells. FASEB J 2010;24:4033-46.
30. Scaruffi P, Stigliani S, Moretti S, Coco S, De Vecchi C, Valdora F, et al. Transcribed-ultra conserved region expression is associated with outcome in high-risk neuroblastoma. BMC Cancer 2009;9:441.
31. Mestdagh P, Fredlund E, Pattyn F, Rihani A, Van Maerken T, Vermeulen J, et al. An integrative genomics screen uncovers ncRNA T-UCR functions in neuroblastoma tumours. Oncogene 2010;29:3583-92.
32. Watters KM, Bryan K, Foley NH, Meehan M, Stallings RL. Expressional alterations in functional ultra-conserved non-coding RNAs in response to all-trans retinoic acid-induced differentiation in neuroblastoma cells. BMC Cancer 2013;13:184.
33. Lal A, Kim HH, Abdelmohsen K, Kuwano Y, Pullmann R Jr, Srikantan S, et al. p16(INK4a) translation suppressed by miR-24. PloS ONE 2008;3:e1864.
34. Faghihi MA, Modarresi F, Khalil AM, Wood DE, Sahagan BG, Morgan TE, et al. Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of beta-secretase. Nat Med 2008;14:723-30.
35. Di Ruscio A, Ebralidze AK, Benoukraf T, Amabile G, Goff LA, Terragni J, et al. DNMT1-interacting RNAs block gene-specific DNA methylation. Nature 2013;503:371-6.
36. Rinn JL, Kertesz M, Wang JK, Squazzo SL, Xu X, Brugmann SA, et al. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 2007;129:1311-23. (Pubitemid 46962090)
37. Mitra SA, Mitra AP, Triche TJ. A central role for long non-coding RNA in cancer. Front Genet 2012;3:17.
38. Lee JT. Epigenetic regulation by long noncoding RNAs. Science 2012;338:1435-9.
39. Zhao Y, Guo Q, Chen J, Hu J, Wang S, Sun Y. Role of long non-coding RNA HULC in cell proliferation, apoptosis and tumor metastasis of gastric cancer: a clinical and in vitro investigation. Oncol Rep 2014;31:358-64.
40. Tsubari M, Tiihonen E, Laiho M. Cloning and characterization of p10, an alternatively spliced form of p15 cyclin-dependent kinase inhibitor. Cancer Res 1997;57:2966-73. (Pubitemid 27315048)
41. Robertson KD, Jones PA. Tissue-specific alternative splicing in the human INK4a/ARF cell cycle regulatory locus. Oncogene 1999;18:3810-20. (Pubitemid 29358559)
42. Williams RT, Barnhill LM, Kuo HH, Lin WD, Batova A, Yu AL, et al. Chimeras of p14ARF and p16: functional hybrids with the ability to arrest growth. PloS ONE 2014;9:e88219.
43. Schmid M, Sen M, Rosenbach MD, Carrera CJ, Friedman H, Carson DA. A methylthioadenosine phosphorylase (MTAP) fusion transcript identifies a new gene on chromosome9p21 that is frequently deleted in cancer. Oncogene 2000;19:5747-54.